GAIN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 USD | +1.75% |
|
-1.02% | -11.18% |
| 04-24 | Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 | CI |
| 04-08 | Gain Therapeutics Names Gene Mack as CFO | MT |
1950f8d872e904df8acdbee6b6.uV8Eu9LtuJlRkr8yVcIOWcLgvNJGAJyACGJPqM58Ewo.8wBD957Z2vcVo9QEH_R9IbXV-aUuVP3ZPzIA5ZwqalncbXz0h4ni9yHc8g~96828c041f935d2a5e285dcb61125e17